SPECTRACURE AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.67 SEK | -6.97% |
|
+6.59% | -30.83% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 623.7 | 2,155 | 1,628 | 571.1 | 487.6 | 374.9 |
| Enterprise Value (EV) 1 | 578.6 | 2,108 | 1,476 | 446.3 | 397.1 | 324.7 |
| P/E ratio | -44.1 x | -159 x | -98.6 x | -24.5 x | -19.2 x | -18.3 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 1,046 x | 2,825 x | 1,344 x | 355 x | - | 1,179 x |
| EV / Revenue | 971 x | 2,762 x | 1,219 x | 278 x | - | 1,021 x |
| EV / EBITDA | -45.8 x | -159 x | -98.9 x | -19.5 x | -15.7 x | -15.5 x |
| EV / FCF | -29.6 x | -105 x | -103 x | -24.1 x | -16.6 x | -11.3 x |
| FCF Yield | -3.38% | -0.96% | -0.97% | -4.14% | -6.03% | -8.82% |
| Price to Book | 9.61 x | 26.3 x | 8.25 x | 3.25 x | 3.24 x | 2.89 x |
| Nbr of stocks (in thousands) | 81,637 | 81,637 | 97,132 | 97,132 | 97,132 | 97,132 |
| Reference price 2 | 7.640 | 26.40 | 16.76 | 5.880 | 5.020 | 3.860 |
| Announcement Date | 5/2/19 | 5/7/20 | 4/28/21 | 4/20/22 | 4/20/23 | 4/18/24 |
1SEK in Million2SEK
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 0.596 | 0.763 | 1.211 | 1.608 | - | 0.318 |
| EBITDA 1 | -12.62 | -13.27 | -14.93 | -22.86 | -25.22 | -20.97 |
| EBIT 1 | -12.82 | -13.56 | -15.32 | -23.32 | -25.73 | -21.47 |
| Operating Margin | -2,151.45% | -1,777.85% | -1,264.99% | -1,450.12% | - | -6,752.83% |
| Earnings before Tax (EBT) 1 | -12.81 | -13.69 | -15.44 | -23.35 | -25.38 | -20.46 |
| Net income 1 | -12.81 | -13.68 | -15.41 | -23.34 | -25.38 | -20.44 |
| Net margin | -2,149.89% | -1,793.58% | -1,272.25% | -1,451.55% | - | -6,427.99% |
| EPS 2 | -0.1733 | -0.1661 | -0.1700 | -0.2403 | -0.2613 | -0.2104 |
| Free Cash Flow 1 | -19.57 | -20.14 | -14.36 | -18.5 | -23.96 | -28.65 |
| FCF margin | -3,283.51% | -2,639.33% | -1,185.79% | -1,150.49% | - | -9,009.28% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 5/2/19 | 5/7/20 | 4/28/21 | 4/20/22 | 4/20/23 | 4/18/24 |
1SEK in Million2SEK
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 45.1 | 47.5 | 152 | 125 | 90.5 | 50.2 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | -19.6 | -20.1 | -14.4 | -18.5 | -24 | -28.6 |
| ROE (net income / shareholders' equity) | -32.7% | -17.9% | -10.8% | -12.5% | -15.6% | -14.6% |
| ROA (Net income/ Total Assets) | -19.2% | -10% | -6.16% | -7.27% | -9.11% | -8.74% |
| Assets 1 | 66.88 | 136.5 | 250 | 321.2 | 278.5 | 234 |
| Book Value Per Share 2 | 0.8000 | 1.000 | 2.030 | 1.810 | 1.550 | 1.340 |
| Cash Flow per Share 2 | 0.5500 | 0.6200 | 1.620 | 1.340 | 0.9600 | 0.5900 |
| Capex | - | 0.92 | 0.44 | 0.16 | 0.56 | - |
| Capex / Sales | - | 120.58% | 36% | 10.2% | - | - |
| Announcement Date | 5/2/19 | 5/7/20 | 4/28/21 | 4/20/22 | 4/20/23 | 4/18/24 |
1SEK in Million2SEK
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -30.83% | 25.43M | |
| -29.66% | 212M | |
| -29.71% | 74.33M |
- Stock Market
- Equities
- SPEC Stock
- Financials SpectraCure AB
